Capvizr
News · All summaries
Healthcare & Life Sciences
Kazia Therapeutics Limited
Series A$120 million
RoundSeries A
Amount$120 million
HQSydney, Australia
DateAugust 28, 2026
THE DEAL, AT A GLANCE

Kazia Therapeutics Limited

From the announcement
Medicine development
What it doesAbout Kazia Therapeutics Kazia Therapeutics Limited ( KZIA ) is an oncology-focused drug development company, based in Sydney, Australia.From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Who is involvedBacked by the Offering primarilyFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
What happenedKazia Therapeutics Limited raised $120M Series A, announced 2026-08-28From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Why it mattersKazia Therapeutics Limited's $120M Series A is a large Healthcare & Life Sciences financing relative to recent tracked sector activity, sitting at the 72th percentile by…From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Kazia Therapeutics Limited · Financing Record

Explore source-linked visual explanations for Kazia Therapeutics Limited. Unsupported claims are withheld while source review continues.

Record 11145 · Recorded date: 2026-08-28

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime